|Articles|May 5, 2023

Pharma 2023: Working with Patient Advocacy Groups

Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how they approach patient engagement.

Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how the role of patient advocacy groups to improve patient engagement, how Roche organizes their relationships and the key takeaways for industry professionals.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Content

Harshit Jain, M.D.

Health Care Made Every Channel Addressable, Except the One in the Room

ByHarshit Jain, M.D.

September 10th 2026

How Life Sciences Companies Can Create Real Impact With Patient Engagement

ByNoël Theodosiou ,Donna R. Cryer, J.D. ,Amy Dorgan

September 10th 2026

Joe Reynolds, Head of User Experience Services at Noble, breaks down what it really takes for pharmaceutical companies to move therapy from the clinic into the patient's home.

The Transition to Home: Why Confidence is Critical to Patient Success

ByJoe Reynolds, Noble

September 9th 2026

Sponsored

Beyond the Segment: How Persona Intelligence Helps Refine HCP Engagement at Scale

ByChristopher Wooden,Tom Woods

August 12th 2026

What 40 Conversations About a Pandemic Taught Me About How Pharma Communicates

ByKishan Rees, M.D.

August 11th 2026

Trending on PharmExec

Artisan Partners’ Director Calls for Novartis Board Shake-Up

340B Under Pressure: Inside Pharma's Push for Greater Clarity

The Agentic AI Revolution in Biopharma

Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes

Pharmaceutical Executive Daily: David Samra Calls For Novartis Board Shake-Up